Related Experiment Video
Updated: May 31, 2026

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
A framework for risk-benefit evaluations in biomedical research
1Institute of Biomedical Ethics, University of Zurich.
Abstract:
Essentially all guidelines and regulations require that biomedical research studies have an acceptable risk-benefit profile. However, these documents offer little concrete guidance for implementing this requirement and determining when it is satisfied. As a result, those charged with risk-benefit evaluations currently assess the risk-benefit profile of biomedical research studies in unsystematic ways, raising concern that some research participants are not being protected from excessive risks and that some valuable studies involving acceptable risk are being rejected. The present paper aims to address this situation by delineating the first comprehensive framework, which is based on existing guidelines and regulations as well as the relevant literature, for risk-benefit evaluations in biomedical research.
More Related Videos
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence studies: Biowaivers
Bioavailability Study Design: Healthy Subjects Versus Patients
Hazard Ratio
For example, in a clinical trial evaluating a...
Ethics in Research
Clinical Trials
There are four phases in a clinical trial. A phase one...

